Cubist And Bristol-Myers Squibb To Continue Partnership

Jan. 13, 2005
Cubist Pharmaceuticals Inc., Cambridge, Mass., and Bristol-Myers Squibb Co., New York, have announced the extension of the three-year collaborative research and license agreement the two entered into in June of 1996. The collaboration focused on ...

Cubist Pharmaceuticals Inc., Cambridge, Mass., and Bristol-Myers Squibb Co., New York, have announced the extension of the three-year collaborative research and license agreement the two entered into in June of 1996. The collaboration focused on treatment of infectious diseases. "The collaboration has worked well, and there is still more work to be done," says Scott M. Rocklage, Ph.D., president and CEO of Cubist. "We are pleased by Bristol-Myers Squibb's commitment to continue the collaboration and to work toward advancing the program to the next level." Cubist Pharmaceuticals is a biopharmaceutical company focused on the research, development, and commercialization of antimicrobial drugs to combat serious and life-threatening bacteria and fungal infections.

Popular Sponsored Recommendations

Beware Extreme Software

Sept. 24, 2023
As a manufacturer, you understand the importance of staying ahead of the curve and being proactive in your approach to technology. With the rapid pace of change in the industry...

What Is Your Smart Factory IQ?

Sept. 24, 2023
It’s time to put Smart, data-driven manufacturing operations to the test. In this comprehensive whitepaper we show you how to determine the Artificial Intelligence Quotient (AIQ...

Shifting Your Business from Products to Service-Based Business Models: Generating Predictable Revenues

Oct. 27, 2023
Executive summary on a recent IndustryWeek-hosted webinar sponsored by SAP

Process Mining For Dummies

Nov. 19, 2023
Here it is. Everything you need to know about process mining in a single book, written in the easy-to-understand, hard-to-forget style that ‘For Dummies’ manages so effortlessly...

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!